<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02940457</url>
  </required_header>
  <id_info>
    <org_study_id>Wuerzburg165/16</org_study_id>
    <nct_id>NCT02940457</nct_id>
  </id_info>
  <brief_title>Cognitive Ability Training for Seniors With Mild Cognitive Impairment</brief_title>
  <acronym>MICE</acronym>
  <official_title>Verbesserung Kognitiver Fähigkeiten Bei Personen Mit Verdacht Auf Eine Leichte Kognitive Beeinträchtigung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuerzburg University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the beneficial effects of prefrontal brain stimulation (with
      transcranial direct current stimulation [tDCS]) during working memory training in seniors
      with mild cognitive impairments.The placebo-controlled double blinded study includes 50
      elderly patients which will be randomized into verum or sham tDCS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this project, we want to test whether the effectiveness of neuropsychological exercise
      therapy can be increased in elderly persons suspected of having an MCI by means of parallel
      tDCS treatment.

      All test participants train over 6 sessions within 2 weeks two different working memory tasks
      with increasing difficulty. In the randomized, double-blind, prospective therapy study,
      participants are assigned to either a Verum-tDCS or a placebo-tDCS group. The Verum-tDCS
      group receives active stimulation in parallel to the exercise therapy, while the placebo
      group does not receive tDCS stimulation. To check the effects of the therapy, we measure
      performance and neuronal activation in different executive tasks using near-infrared
      spectroscopy (NIRS). Furthermore, we will check whether the training increases the volume of
      the grey matter (Draganski et al., 2004, Malchow et al., 2016) and the expression of BDNF can
      be increased (Schuch et al., 2015).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The employe for the study quit and a new grant proposal was not financed
  </why_stopped>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation measured with NIRS</measure>
    <time_frame>4 weeks</time_frame>
    <description>The Investigators are measuring brain activation during executive functions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reaction times, errors and number of generated words in neuropsychological tasks</measure>
    <time_frame>4 weeks</time_frame>
    <description>The Investigators are measuring cognitive performance for different executive functions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>T1 weighted magnetic resonance Imaging (MRI) of the brain</measure>
    <time_frame>4 weeks</time_frame>
    <description>Structural changes in grey matter of the brain calculated by voxel based morphometry (VBM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sampling</measure>
    <time_frame>4 weeks</time_frame>
    <description>Increased BDNF secretion in serum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Verum tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prefrontal anodal stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sham stimulation, same electrode positions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Verum tDCS</intervention_name>
    <description>Neuropsychological (working memory) training for 30 minutes, 6 sessions tDCS during training with 2 mA</description>
    <arm_group_label>Verum tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tDCS</intervention_name>
    <description>Neuropsychological (working memory) training for 30 minutes, 6 sessions tDCS during training with 0 mA</description>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suspected MCI

          -  total CERAD score &lt;= 85.1

          -  MMSE &gt;=24

          -  native german speaker

          -  between 50-75 years old

          -  right handed

        Exclusion Criteria:

          -  impairment of daily living activities

          -  psychiatric, neurological diseases

          -  uncorrected hearing or vision deficits

          -  actual psychopharmaca intake

          -  metal parts in the head

          -  medical electronical implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Herrmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>October 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tDCS</keyword>
  <keyword>MCI</keyword>
  <keyword>Working Memory</keyword>
  <keyword>fNIRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

